Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy

References

• Singh RB, Suh IL, Singh VP. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens 2000;14:749-63
   PubMed Web of Science ®Google Scholar
• Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 2004;18:545-51
   PubMed Web of Science ®Google Scholar
• Jo I, Ahn Y, Lee J, et al. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. J Hypertens 2001;19:1523-32
   PubMed Web of Science ®Google Scholar
• Liu L. Cardiovascular diseases in China. Biochem Cell Biol 2007;85:157-63
   PubMed Web of Science ®Google Scholar
• Chung N-S, Fujita T, Shimamoto K, et al. What is the recommended treatment combination by patient type?. Int J Clin Pract 2006;60:11-13
   Web of Science ®Google Scholar
• Committee for revision of the Chinese guidelines for prevention and treatment of patients with hypertension, Chinese hypertension guidelines, 2005, People's Medical Publishing House, Beijing, China, 2006
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Mancia G, de Backer G, Dominiczak A, et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
   PubMed Web of Science ®Google Scholar
• National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of hypertension 2008. Updated August 2009
   Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European Guidelines on Hypertension Management: a European Society of Hypertension Task Force Document. J Hypertens 2009;27:2121-58
   PubMed Web of Science ®Google Scholar
• Basile J. The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich) 2004;6:621-31
   PubMedGoogle Scholar
• Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens (Greenwich) 2003;5:330-5
   PubMedGoogle Scholar
• Messerli FH. Evolution of calcium antagonists: past, present, and future. Clin Cardiol 2003;26:II-12-16
   Web of Science ®Google Scholar
• Fogari R, Zoppi A, Derosa G, et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007;21:220-4
   PubMed Web of Science ®Google Scholar
• Philipp T, Smith TR, Glazer R, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-80
   PubMed Web of Science ®Google Scholar
• Smith TR, Philipp T, Vaisse B, et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) 2007;9:355-64
   PubMedGoogle Scholar
• Schunkert H, Glazer RD, Wernsing M, et al. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy. Curr Med Res Opin 2009;11:2655-62
   Google Scholar
• Elliott WJ. Is fixed combination therapy appropriate for initial hypertension treatment?. Curr Hypertens Rep 2002;4:278-85
   PubMed Web of Science ®Google Scholar
• Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002;62:443-62
   PubMed Web of Science ®Google Scholar
• Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health-Syst Pharm 2007;64:1279-83
   PubMed Web of Science ®Google Scholar
• Fujita T, Wu Z, Park J-B, et al. Briefings on JHS, CHS, KHS and THS guidelines and their difference from JNC VII and ESC/ESH. Int J Clin Pract 2006;60:3-6
   Web of Science ®Google Scholar
• Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002;4:393-404
   PubMedGoogle Scholar
• Hansson L, Zanchetti A, Carruthers SG, et al. for the HOT Study Group*. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, et al. Prevention of CV events with antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomized controlled trial. Lancet 2005;366:895-906
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28
   PubMed Web of Science ®Google Scholar
• Sinkiewicz W, Glazer RD, Kavoliuniene A, et al. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy. Curr Med Res Opin. 2009;25:315-24
   PubMed Web of Science ®Google Scholar
• Brachmann J, Ansari A, Mahla G, et al. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Adv Ther 2008;25:399-411
   PubMed Web of Science ®Google Scholar
• Schrader J, Salvetti A, Calvo C, et al. The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. Int J Clin Prac 2009;63:217-25
   PubMed Web of Science ®Google Scholar
• Gu D, Reynolds K, Chen XWJ, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920-7
   PubMed Web of Science ®Google Scholar
• Neutel JM. The role of combination therapy in the management of hypertension. Nephrol Dial Transplant 2006;21:1469-74
   PubMed Web of Science ®Google Scholar
• Chrysant SG. Using fixed-dose combination therapies to achieve blood pressure goals. Clin Drug Invest 2008;28:713-34
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Dell’Omo G, Mariani M. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens 2001;15:455-61
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Asknes TA, de la Sierra A, et al. Amlodipine and valsartan; calcium channel blockers/angiotensin II receptor blockers combination for hypertension. Therapy 2007;4:31-40
   Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713-19
   PubMed Web of Science ®Google Scholar
• Heagerty A. Optimizing hypertension management in clinical practice. J Hum Hypertens 2006;20:841-9
   PubMed Web of Science ®Google Scholar
• Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006;47:1039-48
   PubMed Web of Science ®Google Scholar
• Allemann Y, Fraile B, Lambert M, et al. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study. J Clin Hypertens (Greenwich) 2008;10:1-10
   Web of Science ®Google Scholar